LBO — HAMILTON MEDICAL CENTER
IRR: 21.7% | MOIC: 2.67x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
21.7%
IRR
2.67x
MOIC
$189.7M
Entry EV
$346.9M
Exit EV
$97.6M
Equity Invested
Sources & Uses
S&UTotal · $189.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $73.7M | 38.8% | |
| Sub Debt | $18.4M | 9.7% | |
| Equity | $97.6M | 51.5% | |
| Enterprise Value | $184.2M | 97.1% | |
| Transaction Fees | $5.5M | 2.9% | |
| Total Uses | $189.7M | 100.0% |
Interpretation
INTAt 2.67x MOIC and 21.7% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $33.0M |
| Exit Ev | $346.9M |
| Net Debt At Exit | $86.2M |
| Equity At Exit | $260.7M |
| Equity Invested | $97.6M |
| Total Value Created | $163.1M |
| Value From Growth | $153.6M |
| Value From Multiple | $9.2M |
| Value From Deleveraging | $5.9M |